cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2002; 39:790-797
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kühlkamp, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kühlkamp, V.

Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy*

Volker Kühlkamp, MDa,* InSync 7272 ICD World Wide Investigators*

a Medizinische Klinik III, Tübingen, Germany



View larger version (98K):

[in a new window]
 
Figure 1 Typical chest radiograph of a patient with an implantable cardioverter-defibrillator with a right atrial lead, a dual-coil ventricular lead and a left ventricular lead. The left ventricular lead is implanted in a posterolateral vein. The right part of the figure shows a chest radiograph three days after implantation of the system; the left part shows the ap chest radiograph three months of biventricular pacing; note that the cardiothoracic ratio was reduced.

 


View larger version (26K):

[in a new window]
 
Figure 2 Effect of biventricular pacing on the New York Heart Association (NYHA) classification. Patients are grouped according to the severity of heart failure at baseline (NYHA functional class II vs. NYHA functional class III/IV) and follow-up (FU) visit (1-month follow-up visit vs. 3-month follow-up visit). The majority of patients in NYHA functional class II at baseline remained unchanged during follow-up. This is in contrast to patients with NYHA class III/IV heart failure at baseline; 35 patients showed an improvement of at least 1 NYHA functional class at both follow-up visits.

 




 
  cardiology careers collections past issues search home